QuantLogix ← CLX scorecard
📅 CLX Earnings Preview
Clorox Company
Next report (est.)
08/02/2026
Countdown
Imminent
EPS growth YoY
+0.0%
Revenue growth YoY
+0.0%
Options-implied earnings move
±4.7%
The at-the-money straddle prices a move to roughly $97.46 or $88.66 from $93.06 by 09/18/2026.
Implied vs actual — last 8 reports
ReportOptions impliedActual moveMarket was
02/03/2026 ±2.4% +1.5% over-priced
11/03/2025 ±2.3% -3.0% under-priced
05/05/2025 ±2.6% -0.5% over-priced
02/03/2025 ±2.2% +0.7% over-priced
10/30/2024 ±1.2% -0.2% over-priced
04/30/2024 ±1.6% -0.7% over-priced
02/01/2024 ±1.9% +1.9% under-priced
11/01/2023 ±2.4% -2.0% over-priced
Across these reports, options implied an average ±2.1% move vs an actual average of 1.3% — the stock stayed inside the implied band 75% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q4 FY2026 — $0 $0
Q2 FY2026 $1.29 $1.7B $161M
Q1 FY2026 $0.65 $1.4B $82M
Q4 FY2025 $2.68 $2.0B $336M
Analyst posture
Buy / Strong Buy
1
Hold
17
Sell
9
Stable: +0 net change 30d
Live 5-factor engine read: Underweight · 21/100 Full scorecard →
Get alerted before every CLX report — free Full live analysis
🤖 Pro runs a 10-agent AI debate on CLX before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

Clorox Company (CLX) reports imminently, with the next report estimated for 08/02/2026. Across the last 8 reports, options priced an average ±2.1% earnings move while the stock actually moved 1.3% on average — the market has systematically over-priced CLX's earnings risk. Fundamentals into the print: EPS up 0.0% year-over-year, revenue up 0.0%. QuantLogix's live 5-factor engine currently reads CLX as a underweight at 21/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →